$AMOD
ALPHA MODUS HOLDINGS, INC.

2022 Q4 Form 10-K Financial Statement

#000119312523105424 Filed on April 19, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q1 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $270.0K $413.1K $1.310M
YoY Change -21.03% 189.18%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $330.0K $461.9K $1.510M
YoY Change -16.11% 154.64%
Operating Profit -$461.9K -$1.512M
YoY Change
Interest Expense $4.020M $3.841M $14.04M
YoY Change 20.02% 530.77%
% of Operating Profit
Other Income/Expense, Net $3.841M $14.04M
YoY Change 767.98%
Pretax Income $3.690M $3.380M $12.53M
YoY Change 23.59% 1159.5%
Income Tax $380.0K $0.00 $624.6K
% Of Pretax Income 10.3% 0.0% 4.98%
Net Earnings $3.300M $3.379M $11.91M
YoY Change -5.17% 1096.73%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.11 $112.7K $0.40
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q1 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.0K $569.4K $200.0K
YoY Change -77.22% -77.22%
Cash & Equivalents $171.6K $569.4K
Short-Term Investments
Other Short-Term Assets $400.0K $807.0K $400.0K
YoY Change -54.34% -54.34%
Inventory
Prepaid Expenses $367.2K
Receivables
Other Receivables
Total Short-Term Assets $538.8K $1.376M $500.0K
YoY Change -69.29% -71.43%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $244.3M $241.1M $244.3M
YoY Change 1.29% 1.29%
Other Assets
YoY Change
Total Long-Term Assets $244.3M $241.1M $244.4M
YoY Change 1.3% 1.33%
TOTAL ASSETS
Total Short-Term Assets $538.8K $1.376M $500.0K
Total Long-Term Assets $244.3M $241.1M $244.4M
Total Assets $244.9M $242.5M $244.9M
YoY Change 0.79% 0.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $128.8K $119.4K $100.0K
YoY Change 275.26% 194.12%
Accrued Expenses $68.22K $305.3K $300.0K
YoY Change -56.26% -1.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $899.1K $424.6K $900.0K
YoY Change 163.99% 163.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.10M $18.90M $12.10M
YoY Change -95.42% -95.42%
Total Long-Term Liabilities $12.10M $18.90M $12.10M
YoY Change -95.42% -95.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $899.1K $424.6K $900.0K
Total Long-Term Liabilities $12.10M $18.90M $12.10M
Total Liabilities $13.14M $19.32M $13.10M
YoY Change -43.2% -95.04%
SHAREHOLDERS EQUITY
Retained Earnings -$11.89M -$18.02M
YoY Change -44.45%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$11.88M -$18.02M $231.7M
YoY Change
Total Liabilities & Shareholders Equity $244.9M $242.5M $244.9M
YoY Change 0.79% 0.81%

Cashflow Statement

Concept 2022 Q4 2022 Q1 2022
OPERATING ACTIVITIES
Net Income $3.300M $3.379M $11.91M
YoY Change -5.17% 1096.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$80.00K -$223.5K -$827.2K
YoY Change -52.85% -33.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $210.0K
YoY Change -100.03%
Cash From Investing Activities $0.00 $0.00 $205.9K
YoY Change -100.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -85.00K -85.00K
YoY Change -100.0% -100.03%
NET CHANGE
Cash From Operating Activities -80.00K -223.5K -827.2K
Cash From Investing Activities 0.000 0.000 205.9K
Cash From Financing Activities 0.000 -85.00K -85.00K
Net Change In Cash -80.00K -308.5K -706.4K
YoY Change -70.06% -181.19%
FREE CASH FLOW
Cash From Operating Activities -$80.00K -$223.5K -$827.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Registrant Name
EntityRegistrantName
Insight Acquisition Corp. /DE
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001862463
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40775
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3386030
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
333 East 91st Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10128
CY2022 dei City Area Code
CityAreaCode
917
CY2022 dei Local Phone Number
LocalPhoneNumber
374-2922
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
235680000
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
New York, New York
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022Q4 us-gaap Cash
Cash
171583
CY2021Q4 us-gaap Cash
Cash
877937
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
367219
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
876317
CY2022Q4 us-gaap Assets Current
AssetsCurrent
538802
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1754254
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
244314622
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
241187929
CY2022Q4 us-gaap Assets
Assets
244853424
CY2021Q4 us-gaap Assets
Assets
242942183
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
128835
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34332
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68216
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155963
CY2022Q4 inaq Accrued Expenses Related Party Current
AccruedExpensesRelatedPartyCurrent
85000
CY2021Q4 inaq Accrued Expenses Related Party Current
AccruedExpensesRelatedPartyCurrent
10000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
467991
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
149041
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
140274
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
899083
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
340569
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
156593
CY2022Q4 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
12000000
CY2021Q4 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
12000000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
84890
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
10796190
CY2022Q4 us-gaap Liabilities
Liabilities
13140566
CY2021Q4 us-gaap Liabilities
Liabilities
23136759
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11885332
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21395176
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11884732
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21394576
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
244853424
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242942183
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1305836
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
452844
CY2022 us-gaap Taxes Other
TaxesOther
205992
us-gaap Taxes Other
TaxesOther
140274
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1511828
us-gaap Operating Income Loss
OperatingIncomeLoss
-593118
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10711300
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2237915
inaq Offering Costs Associated With Derivative Warrant Liabilities
OfferingCostsAssociatedWithDerivativeWarrantLiabilities
667601
inaq Gain From Expiration Of Over Allotment Option
GainFromExpirationOfOverAllotmentOption
29522
CY2022 inaq Gain Loss From Investments Held In Trust Account
GainLossFromInvestmentsHeldInTrustAccount
-3332546
inaq Gain Loss From Investments Held In Trust Account
GainLossFromInvestmentsHeldInTrustAccount
12071
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14043846
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1587765
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12532018
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
994647
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
624584
CY2022 us-gaap Net Income Loss
NetIncomeLoss
11907434
us-gaap Net Income Loss
NetIncomeLoss
994647
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
inaq Adjustments To Additional Paid In Capital Excess Of Cash Received Over Fair Value Of Private Placement Warrants
AdjustmentsToAdditionalPaidInCapitalExcessOfCashReceivedOverFairValueOfPrivatePlacementWarrants
3219000
inaq Adjustments To Additional Paid In Capital Contribution From Sponsor Upon Transferring Founder Shares To Anchor Investors
AdjustmentsToAdditionalPaidInCapitalContributionFromSponsorUponTransferringFounderSharesToAnchorInvestors
3199500
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
28832723
us-gaap Net Income Loss
NetIncomeLoss
994647
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21394576
CY2022 us-gaap Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
-2397590
CY2022 us-gaap Net Income Loss
NetIncomeLoss
11907434
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11884732
CY2022 us-gaap Net Income Loss
NetIncomeLoss
11907434
us-gaap Net Income Loss
NetIncomeLoss
994647
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10711300
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2237915
inaq Offering Costs Paid Through Promissory Note
OfferingCostsPaidThroughPromissoryNote
-667601
CY2022 inaq Gain Loss From Investments Held In Trust Account
GainLossFromInvestmentsHeldInTrustAccount
-3332546
inaq Gain Loss From Investments Held In Trust Account
GainLossFromInvestmentsHeldInTrustAccount
12071
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-156593
inaq Gain From Expiration Of Over Allotment Option
GainFromExpirationOfOverAllotmentOption
29522
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-509098
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
876317
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
94503
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
12957
CY2022 inaq Increase Decrease In Accrued Expense Related Party
IncreaseDecreaseInAccruedExpenseRelatedParty
72253
inaq Increase Decrease In Accrued Expense Related Party
IncreaseDecreaseInAccruedExpenseRelatedParty
80963
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
467991
CY2022 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
8767
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
140274
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-827207
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1235241
CY2022 inaq Cash Withdrawn From Trust Account
CashWithdrawnFromTrustAccount
205853
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
241200000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
205853
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-241200000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
163132
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
240000000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8700000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
85000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5248690
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
243313178
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-706354
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
877937
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
877937
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171583
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
877937
us-gaap Stock Issued1
StockIssued1
25000
inaq Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
21375
inaq Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
85000
inaq Offering Costs Paid Through Note Payable Related Party
OfferingCostsPaidThroughNotePayableRelatedParty
138132
inaq Deferred Underwriting Commissions In Connection With The Initial Public Offering
DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering
12000000
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-04-20
CY2021Q3 inaq Restrictedinvestmentsterm
Restrictedinvestmentsterm
P185D
CY2022Q4 us-gaap Share Price
SharePrice
10.05
CY2022Q4 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2022Q4 inaq Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination
PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
1
CY2022Q4 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2022Q4 inaq Minimum Share Price Of The Residual Assets Remaining Available For Distribution
MinimumSharePriceOfTheResidualAssetsRemainingAvailableForDistribution
10.05
CY2022Q4 us-gaap Cash
Cash
172000
CY2022Q4 inaq Working Capital Deficit
WorkingCapitalDeficit
360000
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2022 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
163000
CY2021Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
157000
CY2021Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21395176
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18015679
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15181403
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13438998
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
inaq Adjustments To Additional Paid In Capital Excess Of Cash Received Over Fair Value Of Private Placement Warrants
AdjustmentsToAdditionalPaidInCapitalExcessOfCashReceivedOverFairValueOfPrivatePlacementWarrants
3219000
inaq Adjustments To Additional Paid In Capital Contribution From Sponsor Upon Transferring Founder Shares To Anchor Investors
AdjustmentsToAdditionalPaidInCapitalContributionFromSponsorUponTransferringFounderSharesToAnchorInvestors
3199500
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
28832723
us-gaap Net Income Loss
NetIncomeLoss
994647
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21394576
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3379497
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-18015079
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2834276
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-15180803
CY2022Q3 us-gaap Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
-648626
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2391031
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-13438398
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has significant cash balances at financial institutions, which throughout the year regularly exceed the Federal Deposit Insurance Corporation coverage </div></div>limit of $250,000. <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows. </div></div></div><div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: 'Times New Roman';;text-indent: 0px;"/>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div></div>
CY2022 inaq Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
156593
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022 inaq Increase Decrease In Valuation Allowance
IncreaseDecreaseInValuationAllowance
369323
inaq Increase Decrease In Valuation Allowance
IncreaseDecreaseInValuationAllowance
127090
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
369323
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
127090
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
156593
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
24000000
CY2022Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
467991
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-31993
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0
us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-85640
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-95097
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
0
us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
0
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-242233
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-127090
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
624584
CY2022Q4 inaq Deferred Tax Asset Startup Or Organization Costs
DeferredTaxAssetStartupOrOrganizationCosts
369323
CY2021Q4 inaq Deferred Tax Asset Startup Or Organization Costs
DeferredTaxAssetStartupOrOrganizationCosts
95097
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
31993
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
369323
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
127090
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 inaq Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Warrant Liabilities
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeWarrantLiabilities
-0.179
CY2021 inaq Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Warrant Liabilities
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeWarrantLiabilities
-0.473
CY2022 inaq Effective Income Tax Rate Reconciliation Offering Costs Associated With Derivative Warrant Liabilities
EffectiveIncomeTaxRateReconciliationOfferingCostsAssociatedWithDerivativeWarrantLiabilities
0
CY2021 inaq Effective Income Tax Rate Reconciliation Offering Costs Associated With Derivative Warrant Liabilities
EffectiveIncomeTaxRateReconciliationOfferingCostsAssociatedWithDerivativeWarrantLiabilities
0.141
CY2022 inaq Effective Income Tax Rate Reconciliation Gain From Expiration Of Overallotment Option
EffectiveIncomeTaxRateReconciliationGainFromExpirationOfOverallotmentOption
0
CY2021 inaq Effective Income Tax Rate Reconciliation Gain From Expiration Of Overallotment Option
EffectiveIncomeTaxRateReconciliationGainFromExpirationOfOverallotmentOption
-0.006
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.019
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.128
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.05
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-31993
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-95097
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-127090
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q4 inaq Deferred Tax Asset Startup Or Organization Costs
DeferredTaxAssetStartupOrOrganizationCosts
95097
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
31993
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
127090
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
127090
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
inaq Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Warrant Liabilities
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeWarrantLiabilities
-0.473
inaq Effective Income Tax Rate Reconciliation Offering Costs Associated With Derivative Warrant Liabilities
EffectiveIncomeTaxRateReconciliationOfferingCostsAssociatedWithDerivativeWarrantLiabilities
0.141
inaq Effective Income Tax Rate Reconciliation Gain From Expiration Of Overallotment Option
EffectiveIncomeTaxRateReconciliationGainFromExpirationOfOverallotmentOption
-0.006
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.128
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0

Files In Submission

Name View Source Status
0001193125-23-105424-index-headers.html Edgar Link pending
0001193125-23-105424-index.html Edgar Link pending
0001193125-23-105424.txt Edgar Link pending
0001193125-23-105424-xbrl.zip Edgar Link pending
d476136d10k.htm Edgar Link pending
d476136dex12.htm Edgar Link pending
d476136dex311.htm Edgar Link pending
d476136dex312.htm Edgar Link pending
d476136dex321.htm Edgar Link pending
d476136dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
inaq-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
inaq-20221231_cal.xml Edgar Link unprocessable
inaq-20221231_lab.xml Edgar Link unprocessable
inaq-20221231_pre.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d476136d10k_htm.xml Edgar Link completed
inaq-20221231_def.xml Edgar Link unprocessable